Health Care & Hospital Law,
Civil Litigation
Jun. 30, 2021
No evidence promotion increases opioid use, economist testifies
Massive lawsuits in Orange County and New York name some of the same pharmaceutical company defendants and their outcomes will likely affect some 3,000 lawsuits filed nationwide.
Pharmaceutical companies accused of fueling an opioid crisis in California continued their case in chief Tuesday in a $50 billion bench trial in Orange County while a similar jury trial, focused on the entire opioid supply chain, began in New York with opening arguments.
The two massive lawsuits name some of the same defendants and their outcomes will likely affect some 3,000 lawsuits filed nationwide.
$95
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In